Annual report pursuant to Section 13 and 15(d)

Other current assets (Tables)

v3.22.4
Other current assets (Tables)
12 Months Ended
Dec. 31, 2022
Other current assets  
Summary of other current assets

Other current assets consisted of the following (in thousands):

December 31, 

December 31, 

    

2022

    

2021

Research and development credits receivable

 

$

30,162

 

$

30,773

Prepayments

 

9,472

 

9,043

Clinical materials

 

1,279

 

746

VAT receivable

490

2,482

Other current assets

 

1,927

 

2,082

$

43,330

$

45,126